August 20, 2015

Boehringer Ingelheim earlier this week released new data from its clinical trials for its Phase IIIb OTEMTO 1&2 trials, which indicate that Stiolto Respimat provided provided “clinically meaningful improvements” in the St. George’s Respiratory Questionnaire (SGRQ) total score, compared to placebo, in patients with chronic obstructive pulmonary disease, the company said. 

August 20, 2015

Cosmederm Bioscience’s Tri-Calm OTC itch relief solution is quickly climbing the anti-itch treatment product chart with growth of 148.2% to a dollar base of $4.9 million for the 52 weeks ended June 14 across total U.S. multi-outlets, according to IRI.

August 5, 2015

Manufacturers Atrium, Aspen Group, Nutri-Pak of Wisconsin will have to get a special clearance from FDA before producing supplements again. 

July 24, 2015

The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.

July 23, 2015

Lupin announced Thursday that it will acquire Gavis Pharmaceuticals and Novel Laboratories in a $880 million, cash- and debt-free transaction. 

July 16, 2015

The Food and Drug Administration recently issued its final guidance on the appearance of generic pharmaceuticals, recommending that drugs made by generic manufacturers closely mimic the physical attributes, including the size, shape and color, of the drugs that they reference.

July 16, 2015

Ralph Neas, president and CEO of the Generic Pharmaceutical Association, issued a statement last month criticizing the FDA at the organization’s public meeting on the Generic Drug User Free Act.

July 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation, medication synchronization and generics, in this multi-page report.

July 15, 2015

A collection of eight consumer groups have written to Federal Trade Commission chair Edith Ramirez in opposition of the ongoing potential merger between pharmaceutical companies Teva and Mylan. 

July 15, 2015

The Food and Drug Administration is exploring extending PDUFA through 2022. 

July 13, 2015

Theranos is expanding what it started two years ago in the Phoenix market with a new Pennsylvania partnership and a recent FDA approval. 

July 9, 2015

 Mylan announced Thursday that it had launched its generic version of Valeant’s Targretin (bexarotene) 75-mg capsules.

June 30, 2015

The GPhA's Biosimilars Council cautions FDA against adopting distinguishable names for biosimilars and biologics. 

June 23, 2015

The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance. 

June 18, 2015

Rite Aid's latest pharmacy initiative improves patient convenience and medication adherence. 

June 17, 2015

The FDA has introduced a new website for Risk Evaluation and Mitigation Strategies, called REMS@FDA, to provide a standardized source of information about approved REMS.

June 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation and generics, in this multi-page report.

June 15, 2015

Ralph Neas, president and CEO of the Generic Pharmaceutical Association, issued a statement Monday criticizing the FDA at the organization’s public meeting on the Generic Drug User Free Act.

June 15, 2015

Sens. Richard Blumenthal, D-Conn., and Sen. Dick Durbin, D-Ill., proposed three amendments to the National Defense Authorization Act that would impact how the military addresses supplementation. 

June 15, 2015

The credibility of the vitamins, minerals and supplements business has been attacked in recent months.

June 3, 2015

Mylan announced on Tuesday that it had launched its generic version of Teva’s  Seasonique birth control.

May 26, 2015

The 21st Century Cures legislation would foster drug development. 

May 20, 2015

HBO's "Real Sports with Bryant Gumbel" takes a hard look at the sports-nutrition supplements men and women in the military are taking to remain combat ready. 

May 19, 2015

DSN examines chain pharmacy — including in-depth coverage of retail clinics, generics, consolidations, kiosks and more — in this multi-page report.